000756 新华制药
2025/03 -
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资57,970-1.29%58,73058,57257,15456,707
投资性房地产30,996-2.52%31,79733,90948,35445,766
固定资产3,570,9471.69%3,511,4613,325,9453,447,8893,195,112
在建工程733,331-6.12%781,095730,545545,895562,959
无形资产549,663-2.72%565,038494,937474,107466,451
商誉0--0000
其他非流动资产327,553-4.96%344,640327,925234,432251,080
5,270,460-0.42%5,292,7614,971,8334,807,8314,578,075

流动资产
货币资金1,304,5734.78%1,245,023918,3341,158,742744,662
应收账款1,200,30738.25%868,204699,878761,259658,568
存货1,178,376-7.42%1,272,8571,312,9841,211,9871,027,540
其他流动资产316,139-7.22%340,756383,138324,971323,188
3,999,3967.31%3,726,8403,314,3343,456,9592,753,958

流动负债
短期借款496,692-14.39%580,156283,959118,023269,455
应付票据527,04218.67%444,140511,431491,025405,072
应付帐款680,422-4.77%714,540666,413599,056661,320
其他流动负债1,530,65344.84%1,056,7791,024,1981,950,3821,166,034
3,234,81015.71%2,795,6142,486,0003,158,4862,501,880
流动资产净值764,586-17.89%931,226828,333298,474252,078
资产总额减流动负债6,035,046-3.04%6,223,9875,800,1665,106,3054,830,153

非流动负债
长期借款398,341-48.37%771,541799,400545,656346,197
应付债券0--0000
其他非流动负债246,7575.03%234,946225,013211,085832,812
645,098-35.91%1,006,4871,024,413756,7411,179,008

总权益
    实收股本689,7771.08%682,408674,683669,627627,367
    储备项目4,465,7433.63%4,309,1813,878,4213,456,6472,840,574
股东权益5,155,5203.28%4,991,5894,553,1044,126,2743,467,942
非控股权益234,4283.77%225,912222,649223,290183,203